Barclays analyst Jack Meehan raised his price target for Iqvia to $130 saying the Q2 results “demonstrate many of the characteristics that the bulls have been waiting for on the thesis.” Accelerating bookings momentum from the Next Generation platform and deployment of cash to drive earnings up 25% were highlights in the quarter, Meehan tells investors in a post-earnings research note. The analyst reiterates an Overweight rating on the shares.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.